GS-2121

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-2121, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors [Phase 1]